5a), approved for the treatment of amyotrophic lateral sclerosis, increases ROS levels by multiple mechanisms, including decreasing LDH-A and NAD + levels to increase oxidative stress, as well as interfering with the xCT antiporter to block the cystineglutamate pump
Programs may start from a customer-supplied small molecule, an expected metabolite structure, or a labeled-handle concept, and can be aligned with broader amino acid conjugation, custom bioconjugation services, or thiol-reactive route planning informed by maleimide conjugation considerations when appropriate
As scientists dive deeper into the BPC 157 pool, well hopefully get clearer answers
Quick Database Links No UniProt data available Documents Download Request a Document
J Immunol (Baltimore Md 1950) (2008) 181(12):87616